Patents by Inventor Javad GOLJI

Javad GOLJI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS TO TREAT CANCER
    Publication number: 20250101435
    Abstract: The disclosure provides novel personalized therapies, kits, transmittable forms of information and methods for use in treating patients having cancer, wherein the cancer is amenable to therapeutic treatment with an inhibitor, e.g., an inhibitor of any of the targets disclosed herein. Kits, methods of screening for candidate inhibitors, and associated methods of treatment are also provided.
    Type: Application
    Filed: May 15, 2024
    Publication date: March 27, 2025
    Inventors: Eric BILLY, Antoine DE WECK, Javad GOLJI, Gregory HOFFMAN, Francesco HOFMANN, Audrey KAUFFMANN, Konstantinos John MAVRAKIS, Earl Robert MCDONALD, III, William SELLERS, Tobias SCHMELZLE, Frank Peter STEGMEIER, Michael Ray SCHLABACH, Jr.
  • COMPOSITIONS AND METHODS TO TREAT CANCER
    Publication number: 20240052354
    Abstract: The disclosure provides novel personalized therapies, kits, transmittable forms of information and methods for use in treating patients having cancer, wherein the cancer is amenable to therapeutic treatment with an inhibitor, e.g., an inhibitor of any of the targets disclosed herein. Kits, methods of screening for candidate inhibitors, and associated methods of treatment are also provided.
    Type: Application
    Filed: October 19, 2022
    Publication date: February 15, 2024
    Inventors: Eric BILLY, Antoine DE WECK, Javad GOLJI, Gregory HOFFMAN, Francesco HOFMANN, Audrey KAUFFMANN, Konstantinos John MAVRAKIS, Earl Robert MCDONALD, III, William SELLERS, Tobias SCHMELZLE, Frank Peter STEGMEIER, Michael Ray SCHLABACH, JR.
  • Compositions and methods to treat cancer
    Patent number: 11530413
    Abstract: The disclosure provides novel personalized therapies, kits, transmittable forms of information and methods for use in treating patients having cancer, wherein the cancer is amenable to therapeutic treatment with an inhibitor, e.g., an inhibitor of any of the targets disclosed herein. Kits, methods of screening for candidate inhibitors, and associated methods of treatment are also provided.
    Type: Grant
    Filed: July 20, 2018
    Date of Patent: December 20, 2022
    Assignee: Novartis AG
    Inventors: Eric Billy, Antoine De Weck, Javad Golji, Gregory Hoffman, Francesco Hofmann, Audrey Kauffmann, Konstantinos John Mavrakis, Earl Robert McDonald, III, William Sellers, Tobias Schmelzle, Frank Peter Stegmeier, Michael Ray Schlabach, Jr.
  • COMPOSITIONS AND METHODS TO TREAT CANCER
    Publication number: 20210155932
    Abstract: The disclosure provides novel personalized therapies, kits, transmittable forms of information and methods for use in treating patients having cancer, wherein the cancer is amenable to therapeutic treatment with an inhibitor, e.g., an inhibitor of any of the targets disclosed herein. Kits, methods of screening for candidate inhibitors, and associated methods of treatment are also provided.
    Type: Application
    Filed: July 20, 2018
    Publication date: May 27, 2021
    Inventors: Eric BILLY, Antoine DEWECK, Javad GOLJI, Gregory HOFFMAN, Francesco HOFMANN, Audrey KAUFFMANN, Konstantinos John MAVRAKIS, Earl Robert MCDONALD, III, William SELLERS, Tobias SCHMELZLE, Frank Peter STEGMEIER, Michael Ray SCHLABACH, Jr.